
$5.2B+24% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Revenue reached $5.2B in 2025, compounding +26% a year since 2022 and the pace is picking up. The trailing twelve months are already running at $5.4B, ahead of the last full year.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
$1.5B+18% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Net income was $1.5B in 2025, against $1.3B the year before. Earnings per share moved +39% over the last twelve months. Trailing twelve-month profit stands at $1.7B.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
+24.1%revenue growth, FY 2025
→Revenue grew +24% in 2025 against a five-year average of +15%. Earnings grew more slowly (+18%), so costs are absorbing part of the growth.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
$1.2BFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Free cash flow was $1.2B in 2025. That is the most cash the business has ever thrown off in a year. The trailing twelve months stand at $1.5B.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Of $5.2B in 2025 sales, $1.5B reaches net profit - 29 cents on the dollar. The largest single deduction is producing the product ($3.1B).
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→23 cents of every sales dollar became free cash in 2025, up 24 points since 2022.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→The biggest claim on each sales dollar is capital spending, at 17% of revenue (research and development 4%, stock compensation 0%). That share has fallen since 2022, so the cost of competing is easing.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Operating profit outgrew revenue in only 2 of the last 5 years. Costs are growing roughly in step with the business, so scale isn't yet paying for itself.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→Operating margin widened 32 points to 31% since 2022. After everything, 29 cents of each sales dollar reaches net profit.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→ROE of 17% and ROCE of 14% sit close together, so the returns come from the business itself rather than from borrowing.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
12.6xP/E today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→At 12.6x earnings, the market is paying 24% less than FSLR's own 7-year median of 16.6x. Pessimism is priced in - the question is whether it is deserved.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
6.8%FCF yield today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→Every dollar of market value currently buys 6.8% of annual free cash flow, less than its 11-year median of -3.1% - you are paying up for the same cash.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = the latest balance sheet (2026-06-30), not a fiscal year-end
→The company holds $1.7B in cash against $38M of debt - a net-cash balance sheet, which means a bad year is an inconvenience rather than a threat.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→The company's own capital grew from $6.7B in 2023 to $10.3B (+54%). The business is building book value rather than consuming it.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→The share count grew 0.0% in 2025, averaging 0.3% a year over three years. Your slice of the company shrinks by that much each year unless earnings grow faster.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→FSLR earns 14.4% on the capital it employs, comfortably above the 10% most investors treat as the cost of capital. That is the highest in FSLR's filed history.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→FSLR issued +25% more shares from 2011 to 2025, but revenue per share still rose +51%. The dilution bought more growth than it cost existing holders.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Insiders sold $15M on the open market and bought nothing. Many sales are pre-scheduled diversification rather than a view on the price. A further 14 filings were grants, option exercises or tax withholding, which say nothing either way.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30